Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dennis D G C Peters"'
Autor:
Willemijn S M E Theelen, Thomas Kuilman, Katja Schulze, Wei Zou, Oscar Krijgsman, Dennis D G C Peters, Sten Cornelissen, Kim Monkhorst, Pranamee Sarma, Teiko Sumiyoshi, Lukas C Amler, Stefan M Willems, Johannes L G Blaauwgeers, Carel J M van Noesel, Daniel S Peeper, Michel M van den Heuvel, Marcin Kowanetz
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216864 (2019)
BackgroundIn non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 r
Externí odkaz:
https://doaj.org/article/71ec07804c5045b0afac420650e42855
Autor:
Krijn K. Dijkstra, José G. van den Berg, Fleur Weeber, Joris van de Haar, Arno Velds, Sovann Kaing, Dennis D. G. C. Peters, Ferry A. L. M. Eskens, Derk-Jan A. de Groot, Margot E. T. Tesselaar, Emile E. Voest
Publikováno v:
Frontiers in endocrinology, 12:627819. Frontiers Media SA
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, 12:627819. Frontiers Media S.A.
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, 12:627819. Frontiers Media S.A.
Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) is a poorly understood disease with limited treatment options. A better understanding of this disease would greatly benefit from the availability of representative preclinical models. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b593f0c43d340ac146f31045b6cd17b1
https://hdl.handle.net/11370/fab0756b-5f30-4f43-aa6d-e1408866e72b
https://hdl.handle.net/11370/fab0756b-5f30-4f43-aa6d-e1408866e72b